Neuro42, Inc. — Form D
Neuro42, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-11. The offering totals $7.3M, of which $6.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-06-11
- Form: D
- Accession: 0002026406-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $6.7M
- Remaining: $695K
- Minimum investment: $1
- Investors: 24
- Date of first sale: 2024-05-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515635
Issuer
- Name: Neuro42, Inc.
- CIK: 0002026406
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2 BRYANT ST, SAN FRANCISCO, CA, 94105
- Phone: (480) 241-3211
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Shibu R Gangadharan | Executive Officer | San Francisco, CA |
| Krishna R Bhupal | Director | San Francisco, CA |
| Amit Vohra | Director | Oakland, CA |
| Amit Vohra | Executive Officer | Oakland, CA |
| Rahul R Talwar | Director | San Francisco, CA |
| Abhita Batra | Director | San Francisco, CA |
| Abhita Batra | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More